Dynavax Technologies Corp has a consensus price target of $24, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from Goldman Sachs, JMP Securities, and HC Wainwright & Co. on February 1, 2024, November 3, 2023, and November 3, 2023. With an average price target of $25 between Goldman Sachs, JMP Securities, and HC Wainwright & Co., there's an implied 118.72% upside for Dynavax Technologies Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/01/2024 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 74.98% | Goldman Sachs | Paul Choi | → $20 | Initiates | → Neutral | Get Alert |
11/03/2023 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 136.22% | JMP Securities | Roy Buchanan | $25 → $27 | Maintains | Market Outperform | Get Alert |
11/03/2023 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 144.97% | HC Wainwright & Co. | Edward White | $27 → $28 | Maintains | Buy | Get Alert |
08/04/2023 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 136.22% | HC Wainwright & Co. | Edward White | → $27 | Reiterates | Buy → Buy | Get Alert |
08/04/2023 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 118.72% | JMP Securities | Roy Buchanan | $24 → $25 | Maintains | Outperform | Get Alert |
05/03/2023 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 109.97% | JMP Securities | Roy Buchanan | $25 → $24 | Maintains | Outperform | Get Alert |
05/03/2023 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 136.22% | HC Wainwright & Co. | Edward White | → $27 | Reiterates | → Buy | Get Alert |
02/24/2023 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 118.72% | JMP Securities | Roy Buchanan | $22 → $25 | Maintains | Market Outperform | Get Alert |
02/24/2023 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 136.22% | HC Wainwright & Co. | Edward White | $28 → $27 | Maintains | Buy | Get Alert |
11/04/2022 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 83.73% | Goldman Sachs | Madhu Kumar | $24 → $21 | Maintains | Buy | Get Alert |
09/27/2022 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 92.48% | JMP Securities | Roy Buchanan | → $22 | Initiates | → Market Outperform | Get Alert |
12/29/2021 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 144.97% | HC Wainwright & Co. | Edward White | $23 → $28 | Maintains | Buy | Get Alert |
08/31/2021 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 101.22% | HC Wainwright & Co. | Edward White | — | Maintains | Buy | Get Alert |
08/06/2021 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 66.23% | Goldman Sachs | Madhu Kumar | — | Initiates | → Buy | Get Alert |
08/05/2021 | DVAX | Buy Now | Dynavax Technologies | $11.43 | 74.98% | HC Wainwright & Co. | Edward White | — | Maintains | Buy | Get Alert |
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by Goldman Sachs on February 1, 2024. The analyst firm set a price target for $20.00 expecting DVAX to rise to within 12 months (a possible 74.98% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Dynavax Technologies (NASDAQ: DVAX) was provided by Goldman Sachs, and Dynavax Technologies initiated their neutral rating.
There is no last upgrade for Dynavax Technologies.
There is no last downgrade for Dynavax Technologies.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dynavax Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dynavax Technologies was filed on February 1, 2024 so you should expect the next rating to be made available sometime around February 1, 2025.
While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a initiated with a price target of $0.00 to $20.00. The current price Dynavax Technologies (DVAX) is trading at is $11.43, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.